New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Oncotarget
Giuseppe BronteAntonio Russo

Abstract

Anti-epidermal growth factor receptor therapy with the monoclonal antibodies cetuximab and panitumumab is the main targeted treatment to combine with standard chemotherapy for metastatic colorectal cancer. Many clinical studies have shown the benefit of the addition of these agents for patients without mutations in the EGFR pathway. Many biomarkers, including KRAS and NRAS mutations, BRAF mutations, PIK3CA mutations, PTEN loss, AREG and EREG expression, and HER-2 amplification have already been identified to select responders to anti-EGFR agents. Among these alterations KRAS and NRAS mutations are currently recognized as the best predictive factors for primary resistance. Liquid biopsy, which helps to isolate circulating tumor DNA, is an innovative method to study both primary and acquired resistance to anti-EGFR monoclonal antibodies. However, high-sensitivity techniques should be used to enable the identification of a wide set of gene mutations related to resistance.

References

Sep 23, 2000·Nucleic Acids Research·N ThelwellT Brown
Jul 4, 2001·International Journal of Cancer. Journal International Du Cancer·B BaisseJ Benhattar
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Apr 14, 2005·Molecular Cancer Therapeutics·Srikala S SridharLillian L Siu
May 3, 2005·Nature Reviews. Cancer·Nancy E Hynes, Heidi A Lane
Oct 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heinz-Josef LenzEric K Rowinsky
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christoph A RitterCarlos L Arteaga
Sep 6, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Van CutsemM Peeters
Mar 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rafael G AmadoDavid D Chang
Jul 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·K C Allen ChanY M Dennis Lo
Aug 13, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roberto BiancoGiampaolo Tortora
Sep 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Salvatore ArtaleSalvatore Siena
Oct 24, 2008·The New England Journal of Medicine·Christos S KarapetisJohn R Zalcberg
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federica Di NicolantonioAlberto Bardelli
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Randolph HechtRafael G Amado
Feb 5, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sergio BenaventePaul M Harari
Feb 7, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melania PintilieRichard P Hill
Apr 3, 2009·The New England Journal of Medicine·Eric Van CutsemPhilippe Rougier
Apr 16, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hans PrenenSabine Tejpar
Apr 29, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fotios LoupakisAlfredo Falcone
Jul 3, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bart JacobsSabine Tejpar
Sep 10, 2009·Journal of the National Cancer Institute·Salvatore SienaAlberto Bardelli
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan D RichmanPhilip Quirke
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre Laurent-PuigFrédérique Penault-Llorca
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep TaberneroFortunato Ciardiello
Apr 20, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Pierpaolo CorrealeMichele Caraglia
Apr 24, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jolien TolIris D Nagtegaal
Oct 28, 2010·JAMA : the Journal of the American Medical Association·Wendy De RoockSabine Tejpar

❮ Previous
Next ❯

Citations

Mar 11, 2018·Clinical Science·Alberto M MartelliJames A McCubrey
Jun 7, 2019·Database : the Journal of Biological Databases and Curation·Judith Pérez-GranadoLaura I Furlong
Oct 21, 2016·BMC Medical Genomics·Bernard OmoloTimothy J Yeatman
Dec 23, 2016·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S S KumarJ E Hardingham
Sep 11, 2018·Applied Immunohistochemistry & Molecular Morphology : AIMM·Anna M ValentiniMaria L Caruso
Jan 25, 2018·International Journal of Cancer. Journal International Du Cancer·Huanrong MaWangjun Liao
Apr 4, 2017·Expert Opinion on Therapeutic Patents·Daniel PlanoArun K Sharma
Oct 16, 2016·Journal of Translational Medicine·Grazia PalombaGiuseppe Palmieri
Mar 30, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Laurine VersetPieter Demetter
Jun 1, 2017·Expert Review of Molecular Diagnostics·Manish Pratap SinghSameer Srivastava
Sep 30, 2019·Cellular and Molecular Life Sciences : CMLS·Mostafa Akbarzadeh KhiaviYadollah Omidi
Sep 27, 2018·International Journal of Cancer. Journal International Du Cancer·Felix BormannChristine Sers
Apr 21, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jian-Ming XuZhi-Rong Qian
Dec 5, 2019·Genes & Diseases·Mohammad Reza ZinatizadehHabibollah Mahmoodzadeh
Jun 22, 2021·Frontiers in Cell and Developmental Biology·Omayma MazoujiHicham Mansour

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
imaging techniques
PCR
xenograft

Software Mentioned

EVEREST
PRIME
OPUS
CRYSTAL
PICCOLO
BOND
SALVAGE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.